Cargando…

Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies

BACKGROUND: ICD patients with episodes of nonsustained ventricular tachycardias (NSVT) are at risk of appropriate therapies. However, the relationship between the cycle length (CL) of such NSVTs and the subsequent incidence of appropriate interventions is unknown. METHODS: 416 ICD patients with LVEF...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiménez-Candil, Javier, Duran, Olga, Oterino, Armando, Pérez, Jendri, Castro, Juan Carlos, Hernández, Jesús, Moríñigo, José, García, Manuel Sánchez, Sánchez, Pedro L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167949/
https://www.ncbi.nlm.nih.gov/pubmed/34058991
http://dx.doi.org/10.1186/s12872-021-02087-2
_version_ 1783701791010979840
author Jiménez-Candil, Javier
Duran, Olga
Oterino, Armando
Pérez, Jendri
Castro, Juan Carlos
Hernández, Jesús
Moríñigo, José
García, Manuel Sánchez
Sánchez, Pedro L.
author_facet Jiménez-Candil, Javier
Duran, Olga
Oterino, Armando
Pérez, Jendri
Castro, Juan Carlos
Hernández, Jesús
Moríñigo, José
García, Manuel Sánchez
Sánchez, Pedro L.
author_sort Jiménez-Candil, Javier
collection PubMed
description BACKGROUND: ICD patients with episodes of nonsustained ventricular tachycardias (NSVT) are at risk of appropriate therapies. However, the relationship between the cycle length (CL) of such NSVTs and the subsequent incidence of appropriate interventions is unknown. METHODS: 416 ICD patients with LVEF < 45% were studied. ICD programming was standardized. NSVT was defined as any VT of 5 or more beats at ≥ 150 bpm occurred in the first 6 months after implantation that terminated spontaneously and was not preceded by any appropriate therapy. The mean follow-up was 41 ± 27 months. RESULTS: We analyzed 2201 NSVTs (mean CL = 323 ms) that occurred in 250 patients; 111 of such episodes were fast (CL ≤ 300 ms). Secondary prevention (HR = 1.7; p < 0.001), number of NSVT episodes (HR = 1.05; 95% CI 1.04–1.07; p < 0.001) and beta-blocker treatment (HR = 0.7; p = 0.04) were independent predictors of appropriate interventions; however, the mean CL of NSVTs was not (p = 0.6). There was a correlation between the mean CL of NSVTs and the CL of the first monomorphic VT: r = 0.88; p < 0.001. This correlation was especially robust in individuals with > 5 NSVTs (r = 0.97; p < 0.001), with an agreement between both values greater than 95%. Patients with any fast NSVT experienced a higher incidence of VF episodes (26%) compared to those without NVSTs (3%) or with only slow NSVTs (7%); p < 0.001. CONCLUSIONS: Unlike the burden, the CL of NSVTs is not a predictor of subsequent appropriate interventions. However, there is a close relationship between the CL of NSVTs and that of arrhythmias that will later lead to appropriate therapies.
format Online
Article
Text
id pubmed-8167949
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81679492021-06-02 Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies Jiménez-Candil, Javier Duran, Olga Oterino, Armando Pérez, Jendri Castro, Juan Carlos Hernández, Jesús Moríñigo, José García, Manuel Sánchez Sánchez, Pedro L. BMC Cardiovasc Disord Research BACKGROUND: ICD patients with episodes of nonsustained ventricular tachycardias (NSVT) are at risk of appropriate therapies. However, the relationship between the cycle length (CL) of such NSVTs and the subsequent incidence of appropriate interventions is unknown. METHODS: 416 ICD patients with LVEF < 45% were studied. ICD programming was standardized. NSVT was defined as any VT of 5 or more beats at ≥ 150 bpm occurred in the first 6 months after implantation that terminated spontaneously and was not preceded by any appropriate therapy. The mean follow-up was 41 ± 27 months. RESULTS: We analyzed 2201 NSVTs (mean CL = 323 ms) that occurred in 250 patients; 111 of such episodes were fast (CL ≤ 300 ms). Secondary prevention (HR = 1.7; p < 0.001), number of NSVT episodes (HR = 1.05; 95% CI 1.04–1.07; p < 0.001) and beta-blocker treatment (HR = 0.7; p = 0.04) were independent predictors of appropriate interventions; however, the mean CL of NSVTs was not (p = 0.6). There was a correlation between the mean CL of NSVTs and the CL of the first monomorphic VT: r = 0.88; p < 0.001. This correlation was especially robust in individuals with > 5 NSVTs (r = 0.97; p < 0.001), with an agreement between both values greater than 95%. Patients with any fast NSVT experienced a higher incidence of VF episodes (26%) compared to those without NVSTs (3%) or with only slow NSVTs (7%); p < 0.001. CONCLUSIONS: Unlike the burden, the CL of NSVTs is not a predictor of subsequent appropriate interventions. However, there is a close relationship between the CL of NSVTs and that of arrhythmias that will later lead to appropriate therapies. BioMed Central 2021-05-31 /pmc/articles/PMC8167949/ /pubmed/34058991 http://dx.doi.org/10.1186/s12872-021-02087-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jiménez-Candil, Javier
Duran, Olga
Oterino, Armando
Pérez, Jendri
Castro, Juan Carlos
Hernández, Jesús
Moríñigo, José
García, Manuel Sánchez
Sánchez, Pedro L.
Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies
title Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies
title_full Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies
title_fullStr Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies
title_full_unstemmed Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies
title_short Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies
title_sort cycle length of nonsustanied ventricular tachycardias among icd patients: implications on subsequent appropriate therapies
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167949/
https://www.ncbi.nlm.nih.gov/pubmed/34058991
http://dx.doi.org/10.1186/s12872-021-02087-2
work_keys_str_mv AT jimenezcandiljavier cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies
AT duranolga cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies
AT oterinoarmando cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies
AT perezjendri cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies
AT castrojuancarlos cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies
AT hernandezjesus cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies
AT morinigojose cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies
AT garciamanuelsanchez cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies
AT sanchezpedrol cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies